All-cause dementia

There are 325 papers on all-cause dementia in aging research: 1 trial and 263 observational studies in people, 60 reviews. The newest story, Nov 16, 2026: “Air pollution linked to dementia and heart attacks in Scotland”.

Disease

325 papers study it473 more mention it405 findings

32 new papers in 30 daysSee all 798 papers on all-cause dementia

“Adjusted Cox models showed an increased all-cause dementia risk in individuals with UC (HR 1.07, 95% CI 1.04 to 1.10).”
Association between dementia risk and ulcerative colitis, with and without colectomy: a Swedish population-based register studyBMJ open2023doi:10.1136/bmjopen-2023-074110
  • Human trial1
  • Humans263
  • In silico1

Interventions

20

Alcohol

no changein humans1mediatesin humans1RR 1.03

2 studies
  1. Alcohol is linked with all-cause dementia in humans (association between probable sarcopenia and dementia risk) (12.8%).

    “Mediation analysis elucidates that alcohol consumption explained 12.8%, 15.2%, and 11.1% of the associations of probable sarcopenia with the risk of ACD, AD, and VD, respectively.”

    Humansassociation between probable sarcopenia and dementia risk

    Association between probable sarcopenia and dementia risk: a prospective cohort study with mediation analysis

    Translational psychiatry

  2. Alcohol showed no clear effect on all-cause dementia in humans (RR 1.03, 95% CI 0.84–1.27).

    “no significant link between alcohol exposure and the risk of developing dementia, including all-cause dementia (ACD) (RR = 1.03, 95% CI: 0.84-1.27)”

    Review

    Alcohol consumption and risk of dementia: a systematic review and meta-analysis

    Internal medicine journal

More on Alcohol

Mediterranean diet

no changein humans2HR 0.93

2 studies
  1. Mediterranean diet was not clearly linked with all-cause dementia in humans (Fully adjusted model) (HR per SD 1.00, 95% CI 0.94–1.05).

    “Neither Mediterranean nor DASH diet adherence was associated with dementia risk in fully adjusted models”

    HumansFully adjusted modelPer SD of Mediterranean diet scoreMean follow-up of 9.2 years77.5% mensn = 9,095

    Dietary patterns and cardiorespiratory fitness in midlife and subsequent all-cause dementia: findings from the cooper center longitudinal study

    The international journal of behavioral nutrition and physical activity

  2. Mediterranean diet was not clearly linked with all-cause dementia in humans (HR 0.93, 95% CI 0.75–1.15).

    “Neither did adherence to the modified Mediterranean diet lower the risk of developing all-cause dementia”

    HumansmodifiedMedian follow-up, 19.8 years61% womens

    Association Between Dietary Habits in Midlife With Dementia Incidence Over a 20-Year Period

    Neurology

More on Mediterranean diet

Herpes simplex virus type 2 infection

no changein humans1

1 study
  1. Herpes simplex virus type 2 infection showed no clear effect on all-cause dementia in humans (pooled OR ≈ 1.2).

    “when pooling odds ratios across studies examining all-cause dementia, results were non-significant (pooled odds ratios ≈ 1.2, 95% confidence intervals included 1).”

    Review

    Herpes simplex virus 2 and dementia risk: a systematic review and meta-analysis

    Frontiers in dementia

More on Herpes simplex virus type 2 infection

Multidimensional sleep health

no changein humans1

1 study
  1. Multidimensional sleep health was not clearly linked with all-cause dementia in humans (Covariate-adjusted analyses in RS and MAP/MARS) (HRs between 0.72–1.15).

    “Multidimensional sleep health scores and clusters were not significantly associated with accelerated cognitive decline or the risk of dementia in either sample”

    HumansCovariate-adjusted analyses in RS and MAP/MARS10.6 ± 4.5 years in RS; 5.3 ± 2.9 years in MAP/MARS

    Multidimensional self-reported sleep health, cognitive decline, and risk of all-cause dementia: A population-based multi-cohort study

    Journal of Alzheimer's disease : JAD

More on Multidimensional sleep health

Stressful life events

no changein humans1

1 study
  1. Stressful life events were not clearly linked with all-cause dementia in humans (Oldest cohort).

    “Both perceived stress and SLE had no effect in the oldest cohort.”

    HumansOldest cohortMean follow-up of 16 yearsfemales

    The Effect of Stress on All-Cause Dementia: A Longitudinal Analysis From the Australian Longitudinal Study on Women's Health

    The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry

More on Stressful life events

Perceived stress

no changein humans1

1 study
  1. Perceived stress was not clearly linked with all-cause dementia in humans (Oldest cohort).

    “Both perceived stress and SLE had no effect in the oldest cohort.”

    HumansOldest cohortMean follow-up of 16 yearsfemales

    The Effect of Stress on All-Cause Dementia: A Longitudinal Analysis From the Australian Longitudinal Study on Women's Health

    The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry

More on Perceived stress

Taurine

no changein humans1

1 study
  1. Taurine was not clearly linked with all-cause dementia in humans (dietary intake adjusted for energy intake; prospective cohort).

    “No significant associations were found between dietary taurine intake or plasma taurine concentrations and the risk of all-cause dementia, AD, or VaD.”

    Humansdietary intake adjusted for energy intake; prospective cohortdietary intakemedian 25-year follow-upn = 27,786

    Taurine Intake, Plasma Taurine Concentration, and Dementia Risk: Findings From the Malmö Diet and Cancer Study

    Journal of neurochemistry

More on Taurine

Artificially sweetened beverages

no changein humans1HR 1

1 study
  1. Artificially sweetened beverages were not clearly linked with all-cause dementia in humans (HR 1.00, 95% CI 0.99-1.01).

    “for ASB was 1.00 (95% CI, 0.99-1.01; P = .99; I2 = 1%).”

    Humansn = 10,974

    Sweetened Beverages and Incident All-Cause Dementia Among Older Adults

    JAMA psychiatry

More on Artificially sweetened beverages

Sugar-sweetened beverages

no changein humans1HR 0.99

1 study
  1. Sugar-sweetened beverages were not clearly linked with all-cause dementia in humans (HR 0.99, 95% CI 0.98-1.01).

    “The pooled hazard ratio (HR) per serving per week for SSB was 0.99 (95% CI, 0.98-1.01; P = .18; I2 = 0%)”

    Humansn = 10,974

    Sweetened Beverages and Incident All-Cause Dementia Among Older Adults

    JAMA psychiatry

More on Sugar-sweetened beverages

Continuous positive airway pressure

no changein humans1HR 0.99

1 study
  1. Continuous positive airway pressure was not clearly linked with all-cause dementia in humans (HR 0.99, 95% CI 0.74–1.32).

    “Individuals with OSAS who had received continuous positive airway pressure (CPAP) treatment exhibited a similar risk of all-cause dementia as their matched counterparts”

    HumansIndividuals with obstructive sleep apnea syndrome receiving treatment compared with their matched counterparts

    Obstructive sleep apnoea syndrome and future risk of dementia among individuals managed in UK general practice

    Thorax

More on Continuous positive airway pressure

All 20

Upstream

19

Metabolic dysfunction-associated steatotic liver disease

no changein humans2HR 1.04

2 studies
  1. Metabolic dysfunction-associated steatotic liver disease showed no clear effect on all-cause dementia in humans (HR 1.04, 95% CI 0.96–1.11).

    “No significant associations were observed between MASLD and all-cause dementia (HR 1.04, 95% CI 0.96–1.11; I2 = 91%)”

    Review

    MASLD and Risk of Alzheimer's Disease and Vascular Dementia: A Systematic Review and Meta-Analysis of Cohort Studies

    Frontiers in aging neuroscience

  2. Metabolic dysfunction-associated steatotic liver disease showed no clear effect on all-cause dementia in humans (OR 1.03, 95% CI 0.97–1.09).

    “A history of NAFLD was not associated with an increased risk of all-cause dementia”

    Review

    Risk of dementia or cognitive impairment in non-alcoholic fatty liver disease: A systematic review and meta-analysis

    Frontiers in aging neuroscience

More on Metabolic dysfunction-associated steatotic liver disease

GDF-15

mediatesin humans2

2 studies
  1. GDF-15 is linked with all-cause dementia in humans (Mediation of the relationship between physical activity and incident all-cause dementia) (21 unique proteins identified as mediators).

    “GDF15, ITGAV, ITGAM, ITGA11, HPGDS, GFAP, ADM, AHNAK, and DPP4 were among 21 unique proteins found to mediate the relationship of PA with all-cause dementia”

    HumansMediation of the relationship between physical activity and incident all-cause dementiaplasma

    Plasma Proteomic Signatures of Physical Activity Provide Insights into Biological Impacts and its Protective Role against Dementia

    Medicine and science in sports and exercise

  2. GDF-15 is linked with all-cause dementia in humans (mediating the association between degenerative joint diseases and all-cause dementia) (mediation proportion 22%, 95% CI 14.5–46.8%).

    “Mediation analysis revealed that 18 proteins, including HAVCR1 (mediation proportion 52.6 %, 95 % CI: 39.1 %-78 %), GDF15 (22 %, 95 % CI: 14.5 %-46.8 %)”

    Humansmediating the association between degenerative joint diseases and all-cause dementia

    Plasma proteomics mediate the association between degenerative joint diseases and dementia risk

    Journal of advanced research

More on GDF-15

Chronic rhinosinusitis

no changein humans2HR 1–1.04

2 studies
  1. Chronic rhinosinusitis was not clearly linked with all-cause dementia in humans (HR 1.04, 95% CI 0.86–1.26).

    “but was not associated with the risk of all-cause dementia (hazard ratio [HR]: 1.04, 95% CI: 0.86-1.26)”

    Humans

    The association between chronic rhinosinusitis and the risk of dementia: a longitudinal study

    Frontiers in aging neuroscience

  2. Chronic rhinosinusitis was not clearly linked with all-cause dementia in humans (Compared with individuals without chronic rhinosinusitis) (Adjusted HR 1.0, 95% CI 0.8–1.3).

    “patients over 55 years of age with CRS did not exhibit an increased incidence or risk of dementia compared to individuals without CRS.”

    HumansCompared with individuals without chronic rhinosinusitis

    A Longitudinal Study Investigating Whether Chronic Rhinosinusitis Influences the Subsequent Risk of Developing Dementia

    Journal of personalized medicine

More on Chronic rhinosinusitis

Inflammatory bowel disease

no changein humans2RR 1.32

2 studies
  1. Inflammatory bowel disease was not clearly linked with all-cause dementia in humans (Compared with participants without inflammatory bowel disease) (HR 1.14, 95% CI 0.94–1.39; P=.182).

    “Our study does not support a significant association between IBD and dementia.”

    HumansCompared with participants without inflammatory bowel diseaseMean follow-up of 11.58 yearsn = 497,775

    Association Between Inflammatory Bowel Disease and Dementia: A Longitudinal Cohort Study

    Inflammatory bowel diseases

  2. Inflammatory bowel disease showed no clear effect on all-cause dementia in humans (Overall pooled observational studies) (RR 1.32, 95% CI 0.98–1.77).

    “Previous IBD diagnosis did not increased the risk of subsequent all-cause dementia (RR, 1.32; 95% CI, 0.98-1.77)”

    ReviewOverall pooled observational studies

    Inflammatory bowel disease and risk of dementia: An updated meta-analysis

    Frontiers in aging neuroscience

More on Inflammatory bowel disease

IGF-1

no changein humans1HR 1.01

1 study
  1. IGF-1 was not clearly linked with all-cause dementia in humans (Fully adjusted linear Cox model; per 1-SD increase in circulating IGF-1) (HR 1.01, 95% CI 1.00–1.01 per 1-SD increase).

    “a 1‐SD increase in IGF‐1 was not linearly associated with all‐cause dementia (HR = 1.01, 95% CI: 1.00–1.01; p = 0.290).”

    HumansFully adjusted linear Cox model; per 1-SD increase in circulating IGF-1n = 66,535

    Circulating Insulin‐Like Growth Factor‐1, Dementia, and Cognitive Subdomains: Evidence From the <scp>UK</scp> Biobank

    Geriatrics & gerontology international

More on IGF-1

Loneliness

no changein humans1

1 study
  1. Loneliness was not clearly linked with all-cause dementia in humans (total or indirect effects).

    “we found little evidence that hearing phenotypes or loneliness had clear total or indirect effects on Alzheimer's disease dementia or all-cause dementia”

    Humanstotal or indirect effects

    Loneliness as a Pathway Linking Hearing Decline to Cognitive Aging: Longitudinal and Genetic Evidence

    medRxiv : the preprint server for health sciencesPreprint

HAVCR1

mediatesin humans1

1 study
  1. HAVCR1 is linked with all-cause dementia in humans (mediating the association between degenerative joint diseases and all-cause dementia) (mediation proportion 52.6%, 95% CI 39.1–78%).

    “Mediation analysis revealed that 18 proteins, including HAVCR1 (mediation proportion 52.6 %, 95 % CI: 39.1 %-78 %)”

    Humansmediating the association between degenerative joint diseases and all-cause dementia

    Plasma proteomics mediate the association between degenerative joint diseases and dementia risk

    Journal of advanced research

More on HAVCR1

Structural brain changes

mediatesin humans1

1 study
  1. Structural brain changes are linked with all-cause dementia in humans (Association between CKM stage and dementia incidence; mediation analysis) (Up to 15.7% of the CKM-dementia association explained).

    “Mediation analyses indicated that structural brain changes, particularly WMH volume, explained up to 15.7 % of the CKM-dementia association.”

    HumansAssociation between CKM stage and dementia incidence; mediation analysisbrain

    Cardiovascular-kidney-metabolic syndrome, dementia risk, cognition, and neuroimaging outcomes

    Journal of affective disorders

Plasma taurine concentration

no changein humans1

1 study
  1. Plasma taurine concentration was not clearly linked with all-cause dementia in humans (measured in a subset of participants).

    “No significant associations were found between dietary taurine intake or plasma taurine concentrations and the risk of all-cause dementia, AD, or VaD.”

    Humansmeasured in a subset of participantsmedian 25-year follow-upn = 3,693

    Taurine Intake, Plasma Taurine Concentration, and Dementia Risk: Findings From the Malmö Diet and Cancer Study

    Journal of neurochemistry

More on Plasma taurine concentration

PhenoAge-Accel

mediatesin humans1

1 study
  1. PhenoAge-Accel is linked with all-cause dementia in humans (especially among low genetic risk participants).

    “PhenoAge-Accel moderately mediated the influence of air pollution exposure on ACD risk, especially among low genetic risk participants”

    Humansespecially among low genetic risk participantsmedian follow-up of 13.4 yearsn = 285,774

    Roles of Genetic Predisposition and Mediation of Biological Age Acceleration in the Association Between Air Pollution and Dementia

    The journals of gerontology. Series A, Biological sciences and medical sciences

More on PhenoAge-Accel

All 19

Associations

298

Fine particulate matter

upin humans4upin silico1HR 1.16–1.48

5 studies
  1. Fine particulate matter is associated with all-cause dementia in humans (HR 1.48, 95% CI 1.15–1.90).

    “Greater than average annual exposure was associated with an increased risk of all-cause dementia (PM 2.5 , (Hazard Ratio [95% Confidence Interval] (HR [95%CI]) = 1.48 [1.15–1.90]”

    HumansGreater than average annual exposure18 years of follow-up

    Air pollution linked to dementia and heart attacks in Scotland

    Wellcome open research

  2. Fine particulate matter is associated with all-cause dementia in humans.

    “Cox-proportional hazard models reveal associations between pollution exposure and all-cause dementia (PM2.5)”

    Humansover 18 years of follow-up

    Air pollution exposure in Generation Scotland: molecular fingerprints and health outcomes

    Zenodo (CERN European Organization for Nuclear Research)Preprint

  3. Fine particulate matter is associated with all-cause dementia in humans (Exposure in 1935) (HR 1.16, 95% CI 0.90–1.49).

    “all-cause dementia [PM2.5 hazard ratio (HR) = 1.16, 95% confidence interval (CI) = 0.90, 1.49;”

    HumansExposure in 1935Per SD higher exposure (14.03 μg/m3)n = 572

    Life-course exposure to air pollution and the risk of dementia in the Lothian Birth Cohort 1936

    Environmental epidemiology (Philadelphia, Pa.)

  4. Fine particulate matter is associated with all-cause dementia in humans (16% greater hazard per 1 μg/m3; HR 1.16, 95% CI 1.03–1.31).

    “Each 1-μg/m3 increase in the moving average of 10-y PM2.5 was associated with a 16% greater hazard of all-cause dementia”

    HumansEach 1-μg/m3 increase in 10-year average PM2.510-year average exposuren = 4,166

    Fine Particulate Matter and Dementia Incidence in the Adult Changes in Thought Study

    Environmental health perspectives

  5. Fine particulate matter raises the risk of all-cause dementia in silico (OR 1.517, 95% CI 1.049–2.194).

    “genetically predicted PM2.5 was associated with a 51.7% increased risk of ACD (OR = 1.517, 95% CI: 1.049–2.194; p = 0.027)”

    In silico

    Causal Effects of Ambient PM2.5 and Occupational Chemical Exposures on All‐Cause Dementia and Vascular Dementia: A Mendelian Randomization Study

    AAIC 2025 abstract

More on Fine particulate matter

SGLT2 inhibitors

downin humans4OR 0.61–0.85

4 studies
  1. SGLT2 inhibitors are associated with all-cause dementia in humans (Type 2 diabetes; compared with pioglitazone) (aHR 0.78, 95% CI 0.73–0.83).

    “Compared to pioglitazone, SGLT2i use was associated with lower risks of all-cause dementia (aHR 0.78, 95% CI 0.73–0.83)”

    HumansType 2 diabetes; compared with pioglitazoneMean follow-up of 2.9 years

    Comparative effects of SGLT2 inhibitors, pioglitazone, DPP-4 inhibitors, and sulfonylureas on dementia risk in type 2 diabetes

    The journal of prevention of Alzheimer's disease

  2. SGLT2 inhibitors are linked with a lower risk of all-cause dementia in humans (intention-to-treat analysis in patients with mood or psychotic disorders) (OR 0.61 (95% CI 0.52-0.73)).

    “SGLT2 inhibitor use was associated with reduced odds of all-cause dementia (odds ratio [OR], 0.61; 95% CI, 0.52-0.73)”

    Humansintention-to-treat analysis in patients with mood or psychotic disorders

    Drug class linked to lower dementia odds in older psychiatric patients

    JAMA network open

  3. SGLT2 inhibitors are linked with a lower risk of all-cause dementia in humans (compared with DPP-4 inhibitors in type 2 diabetes) (33% lower risk; IRR 0.666 (95% CI 0.484-0.918)).

    “SGLT2 inhibitor use was associated with a 33 % lower risk of all-cause dementia compared to DPP-4 inhibitors”

    Humanscompared with DPP-4 inhibitors in type 2 diabetes

    SGLT2 inhibitors versus DPP-4 inhibitors and dementia risk in type 2 diabetes: A meta-analysis of cohort studies

    Archives of gerontology and geriatrics

  4. SGLT2 inhibitors are associated with all-cause dementia in humans (Type 2 diabetes mellitus; compared with GLP-1 receptor agonist users) (OR 0.85, 95% CI 0.77-0.94).

    “Compared with GLP-1RA users, SGLT-2i users had lower rates of all-cause dementia (OR 0.85, 95% CI 0.77-0.94; P = 0.001)”

    ReviewType 2 diabetes mellitus; compared with GLP-1 receptor agonist users

    SGLT-2 Inhibitors versus GLP-1 Receptor Agonists for Dementia and Depression in Type 2 Diabetes Mellitus: A Meta-Analysis

    Diabetes, metabolic syndrome and obesity : targets and therapy

More on SGLT2 inhibitors

GFAP

upin humans4HR 2.25–2.47

4 studies
  1. GFAP is associated with all-cause dementia in humans (Worst quartile of GFAP) (HR 2.25; 95% CI 1.87-2.72).

    “GFAP (HR 2.25; 95% CI 1.87-2.72) had higher risk of dementia.”

    HumansWorst quartile of GFAP12.2-year median follow-up27.2% femalesn = 5,225

    Blood markers modestly predicted dementia in older adults

    Neurology

  2. GFAP is linked with a higher risk of all-cause dementia in chronic pain individuals; plasma proteomics (HR 2.26 for all-cause dementia (AD HR 2.62; VD HR 2.93)).

    “GFAP showed the strongest association with all dementia types (ACD: HR=2.26; AD: HR=2.62; VD: HR=2.93).”

    Humansin chronic pain individuals; plasma proteomics

    Plasma proteomics reveals novel protein signatures associated with dementia in chronic pain individuals: a prospective cohort study

    AAIC 2025 abstract

  3. GFAP is linked with a higher risk of all-cause dementia in humans (2.32 times more likely).

    “Individuals with higher GFAP levels were 2.32 times more likely to develop dementia.”

    Humansn = 52,645

    Plasma proteomic profiles predict future dementia in healthy adults

    Nature aging

  4. GFAP is associated with all-cause dementia in humans (Without prevalent dementia at baseline) (HR 2.47, 95% CI 1.52–4.01).

    “each standard deviation unit increase in log-transformed GFAP levels was significantly associated with a 2.5-fold higher risk of incident all-cause dementia”

    ReviewWithout prevalent dementia at baselinePer standard deviation increase in log-transformed GFAPUp to 15 yearsn = 4,338

    A population-based meta-analysis of circulating GFAP for cognition and dementia risk

    Annals of clinical and translational neurology

More on GFAP

Physical activity

downin humans3upin humans1+46% higher dementia incidence in individuals without mvpaHR 0.59

4 studies
  1. Physical activity is associated with all-cause dementia in humans (46% higher dementia incidence in individuals without MVPA).

    “the incidence of dementia in individuals without MVPA increased by 46%.”

    HumansNo moderate-to-vigorous physical activityMedian follow-up of 13 yearsn = 220,372

    Physical activity and metabolic syndrome in relation to incident dementia in UK biobank

    Nutrition & metabolism

  2. Physical activity is linked with a lower risk of all-cause dementia in premenopausal females (aHR=0.830, 95% CI 0.739-0.931).

    “Regular physical activity was associated with a reduced risk of all-cause dementia and AD, but not VaD in premenopausal females (aHR=0.830, 95% confidence interval [CI]=0.739-0.931)”

    Humansin premenopausal femalesfemales

    Role of Physical Activity in Protecting Against Dementia According to Menopausal Status

    Journal of clinical neurology (Seoul, Korea)

  3. Physical activity is associated with all-cause dementia in humans (Dementia-free at baseline; midlife physical activity) (Q5 versus Q1: HR 0.59, 95% CI 0.40–0.88; Q4 versus Q1: HR 0.60, 95% CI 0.41–0.89).

    “Midlife and late-life physical activity levels in Q4 or Q5 were associated with lower risk of all-cause dementia compared with Q1”

    HumansDementia-free at baseline; midlife physical activityQ5 versus Q1Mean 25.9 yearsBothsn = 1,943

    Physical Activity Over the Adult Life Course and Risk of Dementia in the Framingham Heart Study

    JAMA network open

  4. Physical activity lowers the risk of all-cause dementia in humans (RR 0·80 [95% CI 0·75-0·86]).

    “high physical activity levels were associated with reduced risks of all-cause dementia (n=146 effect sizes; RR 0·80 [95% CI 0·75-0·86]; I2=97·4%)”

    Reviewmedian follow-up of 10·0 years

    Domain-specific physical activity levels and risk of dementia: a systematic review and meta-analysis

    The Lancet. Public health

More on Physical activity

Hormone replacement therapy

downin humans3upin humans1−17% lower riskHR 0.8–1.12

4 studies
  1. Hormone replacement therapy is linked with a lower risk of all-cause dementia in humans (HR 0.90, 95% CI 0.84-0.96).

    “HRT use was associated with lower all-cause dementia (hazard ratio [HR] 0.90; 95% CI, 0.84-0.96)”

    Humans≥1 yearfemalesn = 183,450

    Hormone replacement therapy and dementia risk among postmenopausal women: Identifying responsive subgroups in the UK Biobank

    Alzheimer's & dementia : the journal of the Alzheimer's Association

  2. Hormone replacement therapy is linked with a lower risk of all-cause dementia in humans (postmenopausal women with type 2 diabetes) (17% lower risk).

    “women who used HRT for more than 5 years had a 17% lower risk compared with those who did not use HRT”

    Humanspostmenopausal women with type 2 diabetesmore than 5 yearsfemalesn = 159,751

    Reproductive Lifespan and Reproductive Factors in Relation to Dementia Risk in Postmenopausal Women With Type 2 Diabetes

    Diabetes care

  3. Hormone replacement therapy is linked with a lower risk of all-cause dementia in postmenopausal women with chronic kidney disease; adjusted Cox regression (HR 0.80; 95% CI 0.78-0.82).

    “HRT was significantly associated with a lower risk for dementia in the adjusted Cox regression model”

    Humansin postmenopausal women with chronic kidney disease; adjusted Cox regressionfemalesn = 755,426

    Menopausal hormone therapy and risk for dementia in women with CKD: A nationwide observational cohort study

    Nephrology (Carlton, Vic.)

  4. Hormone replacement therapy is associated with all-cause dementia in humans (women with a uterus; compared with placebo or no menopausal hormone therapy) (HR 1.12, 95% CI 0.91–1.31).

    “There was no significant increased risk in women with a uterus for all cause dementia (pooled hazard ratio (HR): 1.12; 95% CI 0.91-1.31, N=78,613,”

    Reviewwomen with a uterus; compared with placebo or no menopausal hormone therapysystemicfemalesn = 78,613

    Menopausal hormone therapy at age 45 to 60 years old, future dementia or cognitive decline: Systematic review and meta-analysis

    medRxivPreprint

More on Hormone replacement therapy

Depression

upin humans4HR 1.59–1.75

4 studies
  1. Depression is linked with a higher risk of all-cause dementia in humans (cancer survivors, depression diagnosed >5 years after cancer (time-varying model)) (aHR 2.09, 95% CI 2.02-2.17).

    “time-varying models showed consistently elevated risks across all depression-onset intervals, including >5 years after cancer (aHR, 2.09; 95% CI, 2.02-2.17).”

    Humanscancer survivors, depression diagnosed >5 years after cancer (time-varying model)11.7 years median follow-upn = 385,092

    Interval from Cancer Diagnosis to Depression Onset and Risk of Dementia in Cancer Survivors

    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

  2. Depression is linked with a higher risk of all-cause dementia in humans (HR 1.59, 95% CI 1.50 to 1.69).

    “Depression conferred a 1.59-fold excess risk for dementia (pooled HR: 1.59, 95% CI 1.50 to 1.69; I2=56.8%).”

    Humansn = 220,947

    Associations of physical frailty, depression and their interaction with incident all-cause dementia among older adults: evidence from three prospective cohorts

    General psychiatry

  3. Depression is associated with all-cause dementia in humans (dementia-free at baseline).

    “Our findings unveil a significant association between depression and all-cause dementia, Alzheimer's disease and vascular dementia.”

    Humansdementia-free at baselineaverage follow-up 3.63 years62.4% females

    Effect of depression on risks of Alzheimer's disease and vascular dementia: A real-world longitudinal study

    Psychiatry research

  4. Depression is linked with a higher risk of all-cause dementia in humans (HR = 1.75 [95% CI 1.32-2.34]).

    “The independent factors associated with increased risk of all-cause dementia were depression (HR = 1.75 [95% CI 1.32-2.34])”

    Humansfemales

    Late-Life Risk Factors for All-Cause Dementia and Differential Dementia Diagnoses in Women: A Prospective Cohort Study

    Medicine

More on Depression

Alcohol

upin humans3downin humans1HR 2.34

3 studies
  1. Alcohol is linked with a higher risk of all-cause dementia in humans among only drinking participants (HR 2.34, 95% CI 2.05-2.68).

    “Among only drinking participants, those with MBA had an adjusted HR of 2.34 (95% CI: 2.05-2.68) for all-cause dementia”

    Humansamong only drinking participants

    Associations of mental and behavioral disorders due to tobacco and alcohol use with incident dementia

    Journal of affective disorders

  2. Alcohol is associated with all-cause dementia in APOE e4 carriers.

    “four factors (nonsteroidal anti‐inflammatory drugs, statins, frequent drinking, and high systolic blood pressure) showed significant associations only in APOE ε4 carriers”

    Reviewin APOE e4 carriers

    Roles of APOE e4 in Modulating the Relationship of Non‐genetic Risk Factors with Dementia and Alzheimer’s disease: A System Review and Meta‐analysis of 170 Longitudinal Studies

    AAIC 2025 abstract

  3. Alcohol raises the risk of all-cause dementia in humans (RR 1.18, 95% CI 1.02–1.36).

    “heavy alcohol consumption significantly increased the risk of developing all types of dementia (ACD, RR = 1.18, 95% CI: 1.02-1.36;”

    Reviewheavy alcohol consumption

    Alcohol consumption and risk of dementia: a systematic review and meta-analysis

    Internal medicine journal

  4. Alcohol lowers the risk of all-cause dementia in humans (RR 0.88, 95% CI 0.81–0.96).

    “light to moderate alcohol intake was linked to a decreased risk of ACD and AD”

    Reviewlight to moderate alcohol intake

    Alcohol consumption and risk of dementia: a systematic review and meta-analysis

    Internal medicine journal

More on Alcohol

Smoking

upin humans3RR 1.31

3 studies
  1. Smoking is linked with a higher risk of all-cause dementia in humans (multiplicative interaction with APOE ε4) (p < .001).

    “Smoking indices were associated with ACD risk, with significant multiplicative interactions of PSB (p < .001) and SHS (p = .031) by APOE ε4.”

    Humansmultiplicative interaction with APOE ε4

    Smoking links to dementia risk mainly in APOE ε4 noncarriers

    Biological psychiatry global open science

  2. Smoking is associated with all-cause dementia in humans (New smokers compared with never smokers after ischemic stroke) (aHR 1.395, 95% CI 1.254-1.552).

    “new smokers, sustained smokers, and smoking quitters were significantly associated with a higher risk of all-cause dementia than never smokers”

    HumansNew smokers compared with never smokers after ischemic strokeMedian follow-up of 4.04 yearsn = 197,853

    Risk of dementia according to the smoking habit change after ischemic stroke: a nationwide population-based cohort study

    Scientific reports

  3. Smoking is associated with all-cause dementia in humans (RR 1.31, 95% CI 1.23–1.39).

    “Current smoking was associated with increased risk of all-cause dementia (RR 1.31 [95% CI 1.23–1.39]; number of studies (k) = 39)”

    Reviewcurrent smoking

    Smoking and dementia risk: an updated systematic review and meta-analysis of 61 prospective cohort studies and implications for tobacco control

    EClinicalMedicine

More on Smoking

Diabetes mellitus

upin humans3HR 1.76–2.18

3 studies
  1. Diabetes mellitus is linked with a higher risk of all-cause dementia in humans (compared with participants without diabetes and thyroid disorders) (HR 1.76, 95% CI 1.64–1.89).

    “only diabetes (HR = 1.76, 95% CI = 1.64 to 1.89, P < 0.001)”

    Humanscompared with participants without diabetes and thyroid disorders

    Independent and combined associations of diabetes and thyroid disorders with risks of incident dementia

    Frontiers in endocrinology

  2. Diabetes mellitus is associated with all-cause dementia in humans (Low APOE risk (ε2ε2 or ε2ε3)) (HR 2.18, 95% CI 1.43–3.32).

    “Low social contact, diabetes, and abdominal obesity were top 3 modifiable risk factors associated with an increased risk of dementia”

    HumansLow APOE risk (ε2ε2 or ε2ε3)12.42 years

    Prioritizing Modifiable Risk Factors for Dementia Prevention across the Spectrum of Genetic Susceptibility: A Prospective Cohort Study

    Annals of neurology

  3. Diabetes mellitus is associated with all-cause dementia in humans (Diabetes mellitus at the time of kidney transplantation).

    “Older age and diabetes mellitus at the time of KT were risk factors for incident all-cause dementia and AD in KT recipients.”

    HumansDiabetes mellitus at the time of kidney transplantation

    Incident dementia in kidney transplantation recipients: a matched comparative nationwide cohort study in South Korea

    Kidney research and clinical practice

More on Diabetes mellitus

Periodontal disease

upin humans2downin humans1

2 studies
  1. Periodontal disease is linked with a higher risk of all-cause dementia in humans (weighted median model, alternative approach II (p < 10−4)) (beta: 0.077, 95% CI (0.006, 0.149)).

    “and the weighted median model from alternative approach II (beta: 0.077 95%CI (0.006, 0.149)) suggested potential causal relationship between periodontal diseases and dementia.”

    Humansweighted median model, alternative approach II (p < 10−4)

    Periodontal diseases and all-cause dementia risk: Genetic instrument analyses in half a million UK Biobank participants

    Journal of Alzheimer's disease : JAD

  2. Periodontal disease is linked with a lower risk of all-cause dementia in humans (IVW model, main approach (p < 5 × 10−8)) (beta: -0.816, 95% CI (-1.617, -0.015)).

    “Most MR results suggested no causal association between periodontal diseases and dementia except the IVW model from main approach (coefficient beta: -0.816, 95% confidence interval, CI (-1.617, -0.015))”

    HumansIVW model, main approach (p < 5 × 10−8)

    Periodontal diseases and all-cause dementia risk: Genetic instrument analyses in half a million UK Biobank participants

    Journal of Alzheimer's disease : JAD

  3. Periodontal disease is associated with all-cause dementia in humans (aHR 1.07, 95% CI 1.04-1.09).

    “Periodontal diseases [adjusted hazard ratio (aHR) 1.07, 95% CI 1.04-1.09]”

    Humans

    Association between Dental Diseases and Oral Hygiene Care and the Risk of Dementia: A Retrospective Cohort Study

    Journal of the American Medical Directors Association

More on Periodontal disease

All 298

Trial sponsors

Funding

3 grants since 2019

National Institute on Aging$3.1MUniversity of Southern California$190K

Latest

Dec 2025: 36Jan 2026: 16Feb 2026: 20Mar 2026: 24Apr 2026: 28May 2026: 22Jun 2026: 27Jul 2026: 35Aug 2026: 29Sep 2026: 21Oct 2026: 28Nov 2026: 15301 papers in 12 months
Wellcome Open Research

Air pollution linked to dementia and heart attacks in Scotland

Above-average exposure was linked to dementia and heart attack, with hazard ratios of 1.48 and 1.79, respectively, compared with lower exposure.Above-average exposure was linked to dementia and heart attack, with hazard ratios of 1.48 and 1.79, respectively, compared with lower exposure.

Cohort · 22,071 peopleAll-cause dementia
BMJ

Tighter blood pressure control showed no clear cognitive benefit

Dementia or mild cognitive impairment occurred at 3.69 versus 3.89 events per 100 person-years with intensive versus standard treatment over a median 3.8 years.Dementia or mild cognitive impairment occurred at 3.69 versus 3.89 events per 100 person-years with intensive versus standard treatment over a median 3.8 years.

Randomized trial · 12,434 peopleInterventions

See all 798 papers on all-cause dementia